Article Details
Retrieved on: 2024-07-24 15:18:05
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the performance of European equities in the US, noting declines in companies like Sequans and Cellectis. The key concept 'biopharma' is frequently mentioned, highlighting the fluctuating stock prices of various biopharmaceutical firms.
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here